Drug
2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a clinical trials
Also written HPPH and Photochlor.
- studies test it
- 16
- open now
- 0
- in phase 3
- 0
- first study started
- 1997
How studies write it
Studies that test it under each name
Studies by the year they started
15 studies that test it; most in 2004 (3)
| Year | Studies |
|---|---|
| 1997 | 1 |
| 2000 | 2 |
| 2001 | 1 |
| 2003 | 1 |
| 2004 | 3 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 2 |
| 2015 | 1 |
| 2018 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 15
Roswell Park Cancer Institute (15) · Zhejiang Hisun Pharmaceutical Co. Ltd. (1)
Often tested with
Tested in the same studies.
Photodynamic Therapy (3)
Studies
Open first, then newest update. How each study uses 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a is read from its arms, and is right about nine times in ten.
Testing it · 16
- Photodynamic Therapy Using HPPH in Treating Patients With Stage 0 Non-Small Cell Lung CancerCompletedPhase 1Roswell Park Cancer InstituteNCT00526461Written as HPPH
- Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck CancerCompletedPhase 1Roswell Park Cancer InstituteNCT00470496Written as HPPH
- Photodynamic Therapy With HPPH Compared to Standard of Care Surgery in Treating Patients With Oral Cavity CancerTerminatedPhase 2Roswell Park Cancer InstituteNCT03090412Written as HPPH
- HPPH Photodynamic Therapy for Patients With Esophageal CancerStatus unknownPhase 1Zhejiang Hisun Pharmaceutical Co. Ltd.NCT03757754Written as HPPH 2.5 mg/m2
- Photodynamic Therapy Using HPPH in Treating Patients With Dysplasia, Cancer in Situ, or Invasive Cancer of the LarynxCompletedPhase 1Roswell Park Cancer InstituteNCT00675233Written as HPPH
- A Trial of Photodynamic Therapy With HPPH for Treatment of Dysplasia, Carcinoma in Situ and T1 Carcinoma of the Oral Cavity and/or OropharynxCompletedPhase 1Roswell Park Cancer InstituteNCT01140178Written as HPPH
- Photodynamic Therapy With HPPH in Treating Patients With Squamous Cell Carcinoma of the Oral CavityWithdrawnPhase 2Roswell Park Cancer InstituteNCT02119728Written as HPPH
- Photodynamic Therapy Using HPPH in Treating Patients With Recurrent Dysplasia, Carcinoma in Situ, or Stage I Oral Cavity CancerTerminatedPhase 1Roswell Park Cancer InstituteNCT00670397Written as HPPH
- Study To Determine The Maximum Range of Light Doses At Two HPPH Doses With Acceptable Normal Tissue Toxicity For PDT Treatment Of High Grade Dysplasia,CIS or Early Adenocarcinoma In Barrett's EsophagusCompletedPhase 1Roswell Park Cancer InstituteNCT01238042Written as HPPH
- Photodynamic Therapy in Treating Patients With Lung CancerCompletedPhase 1Roswell Park Cancer InstituteNCT01668823Written as HPPH
- Photodynamic Therapy Using HPPH in Treating Patients With Advanced Non-Small Cell Lung Cancer That Blocks the Air PassagesTerminatedPhase 2Roswell Park Cancer InstituteNCT00528775Written as HPPH
- Study of Photodynamic Therapy (PDT) Using HPPH in Barrett's EsophagusCompletedPhase 1Roswell Park Cancer InstituteNCT01236443Written as HPPH
- Photodynamic Therapy in Treating Patients With Precancerous Esophageal Conditions or Early Stage Esophageal CancerCompletedPhase 2Roswell Park Cancer InstituteNCT00281736Written as HPPH
- Photodynamic Therapy Using HPPH in Treating Patients With Obstructive Esophageal TumorsCompletedPhase 1/2Roswell Park Cancer InstituteNCT00060268Written as HPPH
- Photodynamic Therapy With HPPH in Treating Patients With Non-Small Cell Lung CancerCompletedPhase 1Roswell Park Cancer InstituteNCT00025571Written as HPPH
- Photodynamic Therapy in Treating Patients With Basal Cell Skin CancerCompletedPhase 1Roswell Park Cancer InstituteNCT00017485Written as HPPH